Quick Answer
Dare Bioscience, Inc. reported Net Income Loss of -$13.40 million for the year ending 2025.
- Dare Bioscience, Inc. showed a decrease of -230.6% in Net Income Loss from 2024 to 2025.
- This data is from Dare Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), Dare Bioscience, Inc.'s Net Income Loss has grown by 39.4%.
- Historical annual values: Fiscal year 2025: -$13.40 million | Fiscal year 2024: -$4.05 million | Fiscal year 2023: -$30.16 million | Fiscal year 2022: -$30.95 million | Fiscal year 2021: -$38.70 million | Fiscal year 2020: -$27.40 million | Fiscal year 2019: -$14.26 million | Fiscal year 2018: -$16.74 million | Fiscal year 2017: -$11.50 million | Fiscal year 2016: -$672.7 thousand | Fiscal year 2015: -$39.59 million | Fiscal year 2014: -$23.34 million | Fiscal year 2013: -$17.14 million | Fiscal year 2012: -$22.10 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: